Back to search
FDAFDA · Food and drugs·Recall number D-0576-2025

Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30

Published August 20, 2025 · Recall initiated: July 21, 2025

Summary

FDA records drug Class II recall D-0576-2025, published August 20, 2025 and initiated July 21, 2025. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 8,568 bottles; Lot: Lot 23121560, Exp 4/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: low dissolution results

What to do

Voluntary: Firm initiated · Letter

Get an email if AMLODIPINE AND OLMESARTAN MEDOXOMIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMLODIPINE AND OLMESARTAN MEDOXOMIL
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA
Lot
Lot 23121560, Exp 4/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30 recalled?

Yes. FDA published recall D-0576-2025 on August 20, 2025. Reported hazard: Failed Dissolution Specifications: low dissolution results

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMLODIPINE AND OLMESARTAN MEDOXOMIL.